Poland· PL-100459598
Sugammadex Orion
A sugammadex product containing sugammadexum, registered in Poland by Orion Corporation. The same ATC class is registered in 18 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sugammadex is registered in 18 of 19 countries.
Countries holding a registration under ATC V03AB35 (sugammadex), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Sugammadex · ATC V03AB35
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Sugammadexum
- Manufacturer
- Orion Corporation
- Country
- Poland (PL)
- ATC code
- V03AB35
- ATC class
- Sugammadex
- Defined daily dose
- 0.28 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin06432100100825
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
34 interactions on record for sugammadex.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sugammadex · interactions on record
34 records
- 14 severe
- 20 moderate
Most severe, free to view
- IUP aus Plastik mit GestagenG02BA03severe
- Drospirenone and ethinylestradiolG03AA12severe
- NorethisteroneG03AC01severe
- LevonorgestrelG03AC03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sugammadex in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBLOVOVANVianex S.A., Nea Erythrea
- SpainBRIDION 100 MG/ML SOLUCION INYECTABLEMerck Sharp & Dohme B.V.
- BelgiumBridion 100 mg/mlMerck Sharp & Dohme
- SwedenBridion 100 mg/ml Injektionsvätska, lösningMerck Sharp & Dohme BV
- SwitzerlandBridion 200 mg/2 ml, InjektionslösungMSD Merck Sharp & Dohme AG
- IcelandBridionMerck Sharp & Dohme B.V.*
- NorwaySugammadex BaxterBaxter Holding B.V.
- United StatesBRIDIONMerck Sharp & Dohme LLC
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Areversin, Sugagelan
- Belgium · Sugammadex, Sugammadex Aguettant
- Bulgaria · Сугамадекс Аптафарма, Сугамадекс Ромфарм
- Cyprus · Sugammadex Accord, Sugammadex Anabiosis
- Czechia · Blovovan, Nobridex
- Germany · Areversin, Risvedex Ibi
- Denmark · Sugammadex "aguettant" Aguettant, Sugammadex "kalceks"
- Estonia · Sugammadex Accord, Sugammadex Kalceks
- Spain · Sugammadex, Sugammadex Accord
- Finland · Sugammadex Accord, Sugammadex Aguettant
- France · Sugammadex, Sugammadex Accord
- United Kingdom (Northern Ireland) · Sugammadex, Sugammadex 100 Mg/Ml Solution For Injection Wockhardt Uk
- Greece · Blovovan, Sugammadex Anabiosis
- Croatia · Areversin, Sugamadeks Accord
- Hungary · Areversin, Sugammadex Aguettant
- Ireland · Sugammadex, Sugammadex Accord Healthcare Ireland
- Iceland · Bridion, Sugammadex Amomed
- Italy · Risvedex Ibi, Sugammadex Abdi Farma
- Liechtenstein · Bridion, Sugammadex Amomed
- Lithuania · Sugammadex Accord, Sugammadex Kalceks
- Luxembourg · Sugammadex Eg, Sugammadex Eg (Eurogenerics)
- Latvia · Sugammadex Kalceks, Sugammadex Msn
- Malta · Sugammadex Anfarm, Sugammadex Aspen
- Netherlands · Sugagelan, Sugammadex
- Norway · Bridion, Sugammadex Accord
- Portugal · Sugamadex Accord, Sugamadex Aguettant
- Romania · Areversin, Sugammadex Accord
- Sweden · Sugamadex Galenicum, Sugammadex Accord
- Slovenia · Sugamadeks, Sugamadeks Aptapharma
- Slovakia · Areversin, Sugammadex Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/afdce8da-a85b-4764-90a6-54fea17264ba GET /v1/drugs/afdce8da-a85b-4764-90a6-54fea17264ba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "100 mg/ml",
"packaging": "06432100100825 ¦ Rpz ¦ 150348\n10 fiol. 2 ml",
"substance": "Sugammadexum natricum 100 mg/ml",
"common_name": "Sugammadexum",
"pl_product_id": "100459598",
"pozwolenie_nr": "27845",
"auth_procedure": "DCP",
"authorisation_validity": "2025-11-07"
}See everything about sugammadex.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.